Efficacy and Safety of the Chinese Patent Medicine Yuquan Pill on Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis.

Sihan PengZiyan XieXiyu ZhangChunguang XieJian KangHaipo YuanGang XuXiangeng ZhangYa Liu

Published in: Evidence-based complementary and alternative medicine : eCAM (2021)

Evidence suggested that YQP might improve glucose and lipid metabolism and inflammation in patients with T2DM. Serious adverse events were not reported. The quality of the evidence analyzed was low and therefore our results should be interpreted with caution. More high-quality RCTs are now needed to verify these findings.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
oxidative stress
chronic kidney disease
peritoneal dialysis
glycemic control
type diabetes
blood pressure
quality improvement
blood glucose
fatty acid
patient reported outcomes
cardiovascular risk factors
insulin resistance
patient reported